91
84
Growth Score 91 in past quarter
17 pts
Heat Score 84 in past quarter
83 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3406192
STADA Poland develops and markets prescription medicines, over-the-counter drugs, medical devices, cosmetics, and dietary supplements.
About the Company
STADA Poland develops and markets a broad range of pharmaceutical and consumer healthcare products. The company offers prescription medicines across therapeutic areas, including products such as Dabigatran Eteksylan STADA and Palexia Retard. It supplies over-the-counter medicines and throat care brands like Cholinex and Orofar for cough, cold, and
pain relief. STADA Poland also provides medical devices under brands such as Sinulan, ViruProtect, ViraSoothe, Suplasyn, and Hedrin. Its cosmetics portfolio includes skin and hair care lines such as Nizoral Daily Care and Oilatum Formuła MED creams and conditioners. In addition, the company offers dietary supplements and other health-related products for different age groups.